Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,841.98
+510.05(+1.06%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.2600

-0.3200

(-20.25%)

At close: 04:00PM EDT

1.2700

+0.01

(+0.79%)

After hours:

06:29PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	6.41M
Enterprise value	10.39M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.06
Price/book (mrq)	1.34
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.66
52-week change ³	-84.44%
S&P500 52-week change ³	26.27%
52-week high ³	13.4200
52-week low ³	0.6100
50-day moving average ³	1.5500
200-day moving average ³	4.2484

Share statistics

Avg vol (3-month) ³	611.53k
Avg vol (10-day) ³	82.12k
Shares outstanding ⁵	5.09M
Implied shares outstanding ⁶	6.38M
Float ⁸	2.63M
% held by insiders ¹	28.19%
% held by institutions ¹	39.19%
Shares short (30 Apr 2024) ⁴	23.81k
Short ratio (30 Apr 2024) ⁴	0.2
Short % of float (30 Apr 2024) ⁴	0.47%
Short % of shares outstanding (30 Apr 2024) ⁴	0.47%
Shares short (prior month 28 Mar 2024) ⁴	34.77k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:20
Last split date ³	05 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-59.08%
Operating margin (ttm)	-36.48%

Management effectiveness

Return on assets (ttm)	-33.86%
Return on equity (ttm)	-140.43%

Income statement

Revenue (ttm)	34.07M
Revenue per share (ttm)	22.03
Quarterly revenue growth (yoy)	4.50%
Gross profit (ttm)	N/A
EBITDA	-20.85M
Net income avi to common (ttm)	-20.13M
Diluted EPS (ttm)	-13.0200
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	1.42M
Total cash per share (mrq)	0.28
Total debt (mrq)	5.4M
Total debt/equity (mrq)	112.64%
Current ratio (mrq)	1.28
Book value per share (mrq)	3.16

Cash flow statement

Operating cash flow (ttm)	-24.89M
Levered free cash flow (ttm)	-24.79M